Loading provider…
Loading provider…
Diagnostic Radiology Physician in San Francisco, CA
NPI: 1124106752Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get MD Camilla's Phone Numberphone_androidMobile
Get MD Camilla's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1988 - 2025

American Board of Radiology
Diagnostic Radiology
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1986
Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Fellowship • Neuroradiology
1990 - 1992
UCSF School of Medicine
medschool.ucsf.edu
Residency • Radiology-Diagnostic
1987 - 1991
Fellowship • Neuroradiology
1992 - 1993
University of California (San Francisco)/Mount Zion
Internship • Internal Medicine
1986 - 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 70450CT scan head or brain | 63 | 64 |
| 2 | 72125Ct scan of upper spine without contrast | 17 | 17 |
| 3 | 70498CT scan of neck blood vessels with contrast | 12 | 13 |
| 4 | 70496CT scan of blood vessel of head with contrast | 11 | 12 |
Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations.
Authors: Anthony Barkovich
Journal: AJNR Am J Neuroradiol
Authors: Joseph Sullivan, Cesar Alves, Elizabeth George
Journal: Epilepsia
Publication Date: 2025-02-28
Authors: Yi Li, Mark Mamlouk, Carla Francisco, Elizabeth George, Emmanuelle Waubant, Heather Early
Journal: AJNR Am J Neuroradiol
Publication Date: 2024-02-07
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: LY3202626, DRUG: Donanemab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Donanemab
Lead Sponsor: AstraZeneca
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Lanabecestat